Alvotech Says Adalimumab Story Is ‘Still Being Written’ Ahead Of ‘Critical’ Inspection

Company Confirms It Has Resubmitted Teva-Partnered AVT02 Humira Rival In US

 
• By David Wallace
  
Blue quill pen about to write in blank journal next to stack of old books
The history of US Humira biosimilars is still to be written, Alvotech says • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products